Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
Boston a 'bright spot' for female biotech founders, says report
The latest data identifies biohealth as a bright spot in VC funding for female founders, most significantly in the Northeast.
Signs of hiring at Boston-area life sciences companies
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
Psy Therapeutics to Present at the Virtual Life Science Investor Forum March 13th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at ...
American Association of Individual Investors2d
Why Bicara Therapeutics Inc.’s (BCAX) Stock Is Down 10.28%
Bicara Therapeutics Inc.’s BCAX share price has dipped by 10.28%, which has investors questioning if this is right time to ...
Beam Therapeutics says CRISPR treatment shows encouraging results in lung condition
The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...
American Association of Individual Investors3d
Why Astria Therapeutics, Inc.’s (ATXS) Stock Is Up 11.17%
Astria Therapeutics, Inc.’s ATXS share price has surged by 11.17%, which has investors questioning if this is right time to ...
Business Wire10d
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel ...
Allarity Therapeutics, Inc.: Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission
Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib-a differentiated ...